PCT LTD
Disinfectants Gain B2B Confidence and
Recommendations,
and Addition of
New Distributor
LITTLE
RIVER, SC --
December
23,
2020 --
InvestorsHub NewsWire -- PCT LTD (OTC
Pink: PCTL) today announced that
Len-Tex Wallcoverings,
a leading
manufacturer of contract wallcoverings, providing an extensive
range of design options for the hospitality, healthcare,
corporate, institutional,
and retail
markets, recommended
PCTL's
Hydrolyte® product as an effective
disinfectant.
Len-Tex has been diligently testing
various institutional disinfectants and cleaners on their
wallcovering since the onset of the pandemic. The concern with many
of the disinfectant products has been the tendency of the cleaners
to create a yellowing or discoloration to the wallcovering. After
rigorous testing and research ensuring the compliance of the
cleaning product with the latest standards, they found
Hydrolyte®
effectively
disinfects while protecting the original appearance
and
integrity of their products. To read
more about the testing on the Len-Tex blog visit this
link.
Gary Grieco, PCTL's CEO,
commented, "We are very happy to be
acknowledged as a company delivering
effective and product-safe
disinfectants. Len-Tex is a wonderful company that
has been around for nearly 40 years and we appreciate the lengths
they went through for their clients to test out the best products
for cleaning and disinfecting on the market."
Recently, PCT Corp. brought
on a new Level 2 distributor, a distributor who has executed an
agreement with the Company to sell and distribute our
US EPA
registered products and who is currently beginning
their product sales roll-out. The distributor's headquarters
is in Florida, but their central operations are in Georgia and they are
targeting a very specific, high demand disinfection
market.
About PCT Ltd:
PCT LTD ("PCTL")
focuses its business on acquiring, developing and providing
sustainable, environmentally safe disinfecting, cleaning and
tracking technologies. The company acquires and holds rights to
innovative products and technologies, which are commercialized
through its wholly-owned
operating
subsidiary, Paradigm Convergence Technologies Corporation (PCT
Corp). Currently trading on OTC:PINK, "PCTL"
continues to
be actively engaged in applying
for listing its common stock to the OTC QB
market. The Company established entry into its target markets with
commercially viable products in the United States and now continues
to gain market share in the U.S. and U.K.
ADDITIONAL NEWS
AND CORPORATE UPDATES:
PCTL would like
to warn its stockholders and potential investors that material
corporate information regarding sales, areas of business and other
corporate updates will only be made through press releases or
filings with the SEC. PCTL does not utilize social media, chatrooms
or other online sources to disclose material information.
The public should only rely
on official press releases and corporate filings for accurate and
up to date information regarding PCTL.
Forward-Looking
Statements:
This press
release contains "forward-looking statements" as defined in Section
27A of the Securities Act of 1933, as amended, and Section 21B of
the Securities Exchange Act of 1934, as amended. Any statements
that express or involve discussions with respect to predictions,
expectations, beliefs, plans, projections, objectives, goals,
assumptions or future events or performance are not statements of
historical fact and may be "forward-looking statements."
Such statements
are based on expectations, estimates and projections at the time
the statements are made that involve a number of risks and
uncertainties, which could cause actual results or events to differ
materially from those presently anticipated. Such statements
involve risks and uncertainties, including but not limited to: the
ability of PCTL to fulfill orders; PCTL's
continued installation of equipment;
subsequent installations of PCTL's Annihilyzer Infection Control
Systems and other larger-volume equipment; PCTL's ability to raise
sufficient funds to satisfy its working capital requirements; the
ability of PCTL to execute its business plan; any other effects
resulting from the information disclosed above; risks and effects
of legal and administrative proceedings and government regulation;
future financial and operational results; competition; general
economic conditions; and the ability to manage and continue growth.
Should one or more of these risks or uncertainties materialize, or
should underlying assumptions prove incorrect, actual outcomes may
vary materially from those indicated. Important factors that could
cause actual results to differ materially from the forward-looking
statements PCTL makes in this press release include market
conditions and those set forth in reports or documents it files
from time to time with the SEC. PCTL
undertakes no obligation to revise or update such statements to
reflect current events or circumstances after the date hereof or to
reflect the occurrence of unanticipated events.
Gary Grieco, CEO
and Chairman, PCT LTD
+1(843) 390-7900
Office
www.para-con.com
www.pctcorphealth.com
www.survivalyte.com
Rich Inza,
Investor Relations (RMJ Consulting, LLC)
+1(843)
491-4611
IR@para-con.com
Dave
Donlin, Investor Relations
(The Cervelle Group)
(407) 405-8142
SOURCE PCT
LTD